Vitamin Shoppe Beats Analyst Estimates on EPS

Seth Jayson, The Motley Fool
Updated

Vitamin Shoppe (NYS: VSI) reported earnings on May 7. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended March 30 (Q1), Vitamin Shoppe met expectations on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue increased. Non-GAAP earnings per share expanded significantly. GAAP earnings per share increased.


Gross margins grew, operating margins dropped, net margins grew.

Revenue details
 Vitamin Shoppe logged revenue of $279.1 million. The 10 analysts polled by S&P Capital IQ predicted sales of $278.2 million on the same basis. GAAP reported sales were 13% higher than the prior-year quarter's $248.1 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at $0.72. The 13 earnings estimates compiled by S&P Capital IQ anticipated $0.69 per share. Non-GAAP EPS of $0.72 for Q1 were 16% higher than the prior-year quarter's $0.62 per share. GAAP EPS of $0.68 for Q1 were 11% higher than the prior-year quarter's $0.61 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 36.4%, 80 basis points better than the prior-year quarter. Operating margin was 12.4%, 10 basis points worse than the prior-year quarter. Net margin was 7.5%, 10 basis points better than the prior-year quarter. (Margins calculated in GAAP terms.)

Looking ahead
 Next quarter's average estimate for revenue is $286.5 million. On the bottom line, the average EPS estimate is $0.63.

Next year's average estimate for revenue is $1.10 billion. The average EPS estimate is $2.35.

Investor sentiment
 The stock has a two-star rating (out of five) at Motley Fool CAPS, with 47 members out of 58 rating the stock outperform, and 11 members rating it underperform. Among 24 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 16 give Vitamin Shoppe a green thumbs-up, and eight give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Vitamin Shoppe is outperform, with an average price target of $61.18.

Is Vitamin Shoppe the right retailer for your portfolio? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average retailing powerhouse. Click here for instant access to this free report.

The article Vitamin Shoppe Beats Analyst Estimates on EPS originally appeared on Fool.com.

Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Advertisement